Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes
MD's Q2 earnings benefit from higher patient volumes and a declining expense level. It now projects 2025 adjusted EBITDA within $245-$255 million, up from the prior view of $220-$240 million.
Pediatrix Medical Group, Inc. (MD) Q2 2025 Earnings Call Transcript
Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants Kasandra H. Rossi - Executive VP, Treasurer & CFO Mark S.
Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.34 per share a year ago.
Here's Why Pediatrix Medical Group (MD) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now
MD rises 5.6% YTD as earnings beat, hospital deals and lower costs drive growth. The Zacks Rank #2 signals strong near-term prospects.
Wall Street Analysts See a 26.4% Upside in Pediatrix Medical Group (MD): Can the Stock Really Move This High?
The mean of analysts' price targets for Pediatrix Medical Group (MD) points to a 26.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Pediatrix Medical Group (MD) Shows Fast-paced Momentum But Is Still a Bargain Stock
Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Pediatrix Medical's Q1 Earnings Beat Estimates on Declining Costs
MD anticipates adjusted EBITDA to be between $220 million and $240 million in 2025.
Pediatrix Medical Group (MD) Q1 Earnings and Revenues Surpass Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.20 per share a year ago.
Can Lower Expenses Save Pediatrix Medical's Q1 Earnings?
MD's first-quarter results are likely to reflect declining hospital contract administrative fees.
